Cornerstone Therapeutics Inc. Announces Closing of Chiesi Farmaceutici SpA Transaction
7/30/2009 8:45:22 AM
More...
|
Cornerstone Therapeutics, Inc. Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
5/7/2009 6:57:38 AM
More...
|
Nycomed Canada Solidifies Leadership Position in the Canadian Respiratory Market
6/26/2008 2:58:53 PM
More...
|
Eurand in Licenses Corticosteroid GI Product From Chiesi Farmaceutici SpA
4/15/2008 11:36:55 AM
More...
|
Frost & Sullivan Lauds Chiesi Farmaceutici SpA For Exceptional Technology Innovation In The European Respiratory Diseases Market
2/15/2007 12:58:23 PM
More...
|
Chiesi Farmaceutici SpA To Launch New Modulite (R) HFA Product In The UK
7/25/2006 6:11:45 PM
More...
|
Cambridge Consultants' And Chiesi Farmaceutici SpA's Innovative Dry Powder Inhaler Nears Release
4/20/2006 1:32:45 PM
More...
|
Chiesi Group Reports Financial Results For 2005: Marked Growth Driven By The Pipeline Products
3/7/2006 6:32:27 PM
More...
|
Chiesi Farmaceutici SpA Establishes Russian Affiliate And Forms A Joint Venture In The Netherlands
2/27/2006 3:12:42 PM
More...
|
Chiesi Farmaceutici SpA And SALVAT Sign A Worldwide Development And Licensing Agreement For M3 Muscarinic Receptor Antagonists
1/9/2006 12:30:24 PM
More...
|
|